Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression

Clinical and Experimental Allergy

Volumn 27, Issue 10, 1997, Pages 1175-1183

  Ciprandi, G ^a,d   Pronzato, C ^a   Ricca, V ^b   Passalacqua, G ^a   Danzig, M ^c   Canonica, G W ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Ospedale Koelliker   (Italy)

^c MERCK RESEARCH LABORATORIES   (United States)

^d DIMI   (Italy)

Author keywords

Adhesion molecules; Cetirizine; Epithelial cells; ICAM 1; Inflammatory cells; Loratadine; Pollen allergy; Rhinitis

Indexed keywords

CETIRIZINE; INTERCELLULAR ADHESION MOLECULE 1; LORATADINE;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; EPITHELIUM; FEMALE; HUMAN; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; MALE; POLLEN ALLERGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; BLOOD PROTEINS; CETIRIZINE; EOSINOPHIL GRANULE PROTEINS; EOSINOPHIL PEROXIDASE; EOSINOPHILS; EPITHELIAL CELLS; FEMALE; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTE COUNT; LORATADINE; MALE; NASAL LAVAGE FLUID; NASAL MUCOSA; NEUTROPHILS; PEROXIDASE; PEROXIDASES; RHINITIS, ALLERGIC, SEASONAL; RIBONUCLEASES; SEASONS;

EID: 0030800848     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1997.tb01155.x     Document Type: Article

References (20)

1. Bochner BS, Schleimer RP. The role of adhesion molecules in human eosinophil and basophil recruitment. J Allergy Clin Immunol 1993; 94:427-38.
2. Ciprandi G, Pronzato C, Ricca V, Bagnasco M, Canonica GW. Evidence of intercellular adhesion molecule-1 expression on nasal epithelial cells in acute rhinoconjunctivitis caused by pollen exposure. J. Allergy Clin Immunol 1994; 94:738-46.
3. Ciprandi G, Pronzato C, Ricca V, Passalacqua G, Bagnasco M, Canonica GW. Allergen-specific challenge induces intracellular adhesion molecule-1 (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects. Am J Respir Crit Care Med 1994; 150(6):1653-9.
4. Canonica GW, Pronzato C, Fiorino N, Ciprandi G, Bagnasco M. Adhesion Molecules: a review of their clinical roles in allergic inflammation. Allergy and Clinical Immunology News 1993; 5(3):80-4.
5. Canonica GW, Ciprandi G, Buscaglia S, Pesce GP, Bagnasco M. The adhesion molecules of allergic inflammation: recent insights into their functional roles. Allergy 1994; 49:135-41.
6. Ciprandi G, Buscaglia S, Pesce GP, Bagnasco M, Canonica GW. ICAM-1/CD54 expression on conjunctival epithelium during pollen season. Allergy 1995; 50:184-7.
7. Ciprandi G, Buscaglia S, Pesce GP, Villaggio B, Bagnasco M, Canonica GW. Allergic subjects express intercellular adhesion molcules-1 (ICAM-1 or CD54) on epithelial cells of conjuntiva after allergen challenge. J Allergy Clin Immunol 1993; 91:783-92.
8. Haria M, Fitton A, Peters DH. Loratadine: a reappraisal of its pharmacological properties and therapeutic use in allergic disorders. Drugs 1994; 48:617-37.
9. Bousquet J, Czarlewski W, Danzig MR. Antiallergic properties of loratadine: a review. Advances in Therapy 1995; 12:283-98.
10. Vignola AM, Crampette L, Mondain A. Inhibitory activity of loratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cells. Allergy 1995; 50:200-3.
11. Staquet MJ, Reano A, Schmitt D, Czarlewski W. Loratadine downregulates ICAM-1 induced expression on normal human epidermal cells. J Allergy Clin Immunol 1995; 1(pt2):299.
12. Ciprandi G, Pronzato C, Ricca V, Varese P, Del Giacco GS, Canonica GW. Terfenadine exerts antiallergic activity reducing ICAM-1 expression on nasal epithelial cells in patients with pollen allergy. Clin Exp Allergy 1995; 25:871-8.
13. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, McDonald S, Pulford KAF, Stein H, Mason DY. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAAP complexes). J Histochem Cytochem 1984; 32:219-45.
14. Baggiolini M, Dahinden CA. CC chemokines in allergic inflammation. Immunol Today 1994; 3:127-33.
15. Frew AJ. Cytokines, chemokines, T cells and allergy. Clin Exp Allergy 1996; 26:2-4.
16. Sim TC, Grant A, Hilsmeier KA, Fukuda Y, Alam R. Proinflammatory cytokines in nasal secretions of allergic subjects after antigen challenge. Am Respir Crit Care Med 1994; 149:339-44.
17. Altman LC, Garrison HA, Baker C, Luchtel DL. Cytokines and eosinophil-derived cationic proteins upregulate intercellular adhesion molecule-1 on human nasal epithelial cells. J Allergy Clin Immunol 1993; 92:527-36.
18. Ciprandi G, Buscaglia S, Pesce GP, Canonica GW. Protective effect of loratadine on specific conjunctival provocation test. Int Arch Allergy Appl Immunol 1991; 96:344-7.
19. Ciprandi G, Buscaglia S, Marchesi E, Danzig M, Cuss F. Canonica GW. Protective effect of loratadine on late phase reaction induced by conjunctival provocation test. Int Arch Allergy Immunol 1994; 100:185-9.
20. Ciprandi G, Buscaglia S, Pesce GP, Passalacqua G, Rihoux JP, Bagnasco M, Canonica GW. Cetirizine reduces ICAM-1 expression both in early and late phase events following allergen-specific conjunctival challenge. J. Allergy Clin Immunol 1995; 95:612-21.